Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ultragenyx Pharmaceutical Inc (RARE)  
$42.61 1.49 (3.62%) as of 4:30 Thu 5/16


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 82,110,000
Market Cap: 3.50(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.73 - $53.69
Level I Sector: Consumer Discretionary
Level II Sector: Leisure
Level III Sector: Restaurants

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ COMPOSITE
    NASDAQ INDUSTRIAL     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Co. has four commercially approved products, Crysvita® (burosumab) for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia, Mepsevii® (vestronidase alfa) for the treatment of mucopolysaccharidosis VII, or Sly Syndrome, Dojolvi® (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders, and Evkeeza® (evinacumab) for the treatment of homozygous familial hypercholesterolemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 39,487 99,487 200,738 249,694
Total Sell Value $2,038,634 $4,824,734 $8,307,365 $10,494,293
Total People Sold 7 8 9 12
Total Sell Transactions 10 12 21 35
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 628
  Page 15 of 26  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Parschauer Karah Herdman EVP and General Counsel   •       –      –    2019-04-19 4 D $64.43 $15,979 D/D (248) 20,048     -
   Kassberg Thomas Richard CBO & EVP   •       –      –    2019-04-19 4 D $64.43 $15,979 D/D (248) 89,226     -
   Sharp Shalini CFO & Executive Vice President   •       –      –    2019-03-18 4/A AS $70.00 $1,036,000 D/D (14,800) 66,326     -
   Sharp Shalini CFO & Executive Vice President   •       –      –    2019-03-18 4/A OE $6.86 $82,320 D/D 12,000 81,126     -
   Sharp Shalini CFO & Executive Vice President   •       –      –    2019-03-18 4 AS $70.00 $1,036,000 D/D (14,800) 66,357     -
   Sharp Shalini CFO & Executive Vice President   •       –      –    2019-03-18 4 OE $6.86 $82,320 D/D 12,000 81,157     -
   Parschauer Karah Herdman EVP and General Counsel   •       –      –    2019-03-05 4/A S $65.52 $58,051 D/D (886) 20,296     -
   Kassberg Thomas Richard CBO & EVP   •       –      –    2019-03-05 4/A S $65.52 $54,513 D/D (832) 89,474     -
   Huizenga Theodore Alan VP, Controller and PAO   •       –      –    2019-03-05 4/A S $65.52 $16,642 D/D (254) 15,642     -
   Kakkis Emil D President & CEO   •       •      –    2019-03-05 4/A S $65.52 $189,353 D/D (2,890) 467,583     -
   Sharp Shalini CFO & Executive Vice President   •       –      –    2019-03-05 4/A S $65.52 $66,306 D/D (1,012) 69,125     -
   Pinion John Richard See Remarks   •       –      –    2019-03-05 4/A S $65.52 $47,305 D/D (722) 36,966     -
   Huang Dennis Karl EVP & Chief Tech Ops Officer   •       –      –    2019-03-05 4/A S $65.52 $41,016 D/D (626) 21,693     -
   Parschauer Karah Herdman EVP and General Counsel   •       –      –    2019-03-01 4/A A $0.00 $0 D/D 7,000 21,182     -
   Kassberg Thomas Richard CBO & EVP   •       –      –    2019-03-01 4/A A $0.00 $0 D/D 7,000 90,306     -
   Huizenga Theodore Alan VP, Controller and PAO   •       –      –    2019-03-01 4/A A $0.00 $0 D/D 1,390 15,896     -
   Kakkis Emil D President & CEO   •       •      –    2019-03-01 4/A A $0.00 $0 D/D 20,000 470,473     -
   Pinion John Richard See Remarks   •       –      –    2019-03-01 4/A A $0.00 $0 D/D 20,000 37,688     -
   Huang Dennis Karl EVP & Chief Tech Ops Officer   •       –      –    2019-03-01 4/A A $0.00 $0 D/D 6,000 22,319     -
   Hogenhuis Wladimir Chief Operating Officer   •       –      –    2019-03-01 4 A $0.00 $0 D/D 5,000 20,000     -
   Kassberg Thomas Richard CBO & EVP   •       –      –    2019-03-01 4 D $67.55 $54,445 D/D (806) 89,499     -
   Kassberg Thomas Richard CBO & EVP   •       –      –    2019-03-01 4 A $0.00 $0 D/D 7,000 90,305     -
   Pinion John Richard See Remarks   •       –      –    2019-03-01 4 D $67.55 $47,353 D/D (701) 36,986     -
   Pinion John Richard See Remarks   •       –      –    2019-03-01 4 A $0.00 $0 D/D 20,000 37,687     -
   Bedrosian Camille L EVP and Chief Medical Officer   •       –      –    2019-03-01 4 A $0.00 $0 D/D 7,000 23,364     -
  628 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 15 of 26
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us